查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1877432

勃起功能障礙市場：依應用、治療類型、產品類型、配銷通路、國家及地區分類－全球產業分析、市場規模、市場佔有率及2025-2032年預測

Erectile Dysfunction Market, By Application, By Therapy Type, By Product Type, By Distribution Channel, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 397 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年，勃起功能障礙市場規模價值 25.6787 億美元，從 2025 年到 2032 年，複合年成長率為 8.2%。

勃起功能障礙（ED）是指持續無法達到或維持足以進行滿意度生活的勃起狀態。它是一種多因子疾病，由血管、神經、荷爾蒙或心理因素引起，對男性的身心健康產生重大影響。心血管疾病和糖尿病等慢性疾病在全球範圍內的日益流行，以及久坐不動的生活方式和壓力相關疾病，都是導致ED的重要因素，也是推動市場發展的關鍵因素。然而，威而鋼和希愛力等重磅藥物專利到期，導致價格下降和學名藥的激烈競爭，從而限制了市場發展。儘管如此，新一代口服療法、幹細胞療法以及提供線上諮詢和處方服務的數位健康平台的開發，為市場帶來了新的機會。這些創新，加上人們越來越認知到性健康是男性健康的重要組成部分，有望推動勃起功能障礙市場的長期成長和現代化。

勃起功能障礙市場－市場動態

生活方式相關疾病盛行率上升將推動市場成長

生活方式相關疾病的日益普遍預計將推動勃起功能障礙市場的發展。生活型態相關疾病是指主要由不良習慣（例如飲食不健康、缺乏運動、吸菸和酗酒）所引起的健康問題。生活方式相關疾病的增加歸因於久坐行為的增加、不良飲食習慣、壓力以及吸煙和過量飲酒等不良習慣。勃起功能障礙（ED）是心血管疾病和糖尿病等生活方式相關疾病的早期預警訊號，凸顯了及時就醫和選擇更健康生活方式的重要性。例如，根據總部位於英國的非營利組織世界肥胖聯盟於2022年5月發布的報告，到2030年，全球將有10億人肥胖，其中包括五分之一的女性和七分之一的男性；到2035年，肥胖人口將增至40億，佔全球人口的51%。因此，生活方式相關疾病的日益普遍將推動勃起功能障礙行業的成長。

勃起功能障礙市場細分分析：

全球勃起功能障礙市場按應用、治療類型、產品類型、配銷通路和地區進行細分。

根據該申請，由於希愛力（Cialis）、Stendra、威而鋼（Viagra）等口服藥物的使用量增加（這些藥物可自行服用且經濟實惠），以及市場參與者之間合作與夥伴關係的加強，預計到2025年，口服藥物將成為全球勃起功能障礙藥物市場中收入最高的細分市場。例如，2022年5月，Laboratorios Rubio SA將處方藥BANDOL（西地那非口服懸浮液）出售給了Aspargo Laboratories, Inc.。 BANDOL用於治療勃起功能障礙。同時，Aspargo與Rubio簽署了一項分銷協議，繼續在西班牙市場銷售和推廣BANDOL。

按配銷通路，由於勃起功能障礙發病率不斷上升，促使人們尋求更快更有效的替代療法，以及先進平台的不斷湧現，在線藥房已成為全球勃起功能障礙藥物市場最重要的銷售管道。例如，致力於透過安全的遠距醫療平台開發、行銷和銷售一系列男性健康產品的公司Mangoceuticals, Inc.，將於2023年10月透過其全新改版的網站推出聯盟行銷計畫。該公司旗下品牌「Mango」專門研發治療勃起功能障礙（ED）的藥物。

勃起功能障礙市場—地理洞察

北美是治療勃起功能障礙（ED）藥物市場的重要收入來源地，這得益於ED的高發病率、先進的醫療基礎設施以及廣泛的患者教育。該地區擁有強大的研發能力，並聚集了輝瑞公司（威而鋼）和禮來公司（希愛力）等領先的製藥公司，這些公司不斷透過新型配方和聯合療法進行創新。較高的可支配收入、更便利的醫療服務以及有利的報銷機制都促進了市場的長期需求。然而，專利到期和學名藥的日益普及加劇了競爭，並影響了定價策略。根據牛津學術出版社（2024年2月）的數據，北美ED的平均盛行率為20.7%，且在各個年齡層以及伴隨其他健康問題的人群中均呈現持續成長的趨勢，凸顯了該地區在臨床和商業領域的持續重要性。

美國勃起功能障礙市場—國家概況

美國對北美勃起功能障礙藥物市場貢獻巨大。人口老化加劇、糖尿病和高血壓等生活方式相關疾病的流行，以及人們對勃起功能障礙治療方案日益成長的認知，都推動了市場成長。輝瑞和禮來等製藥公司佔有重要地位，透過包括零售藥局和線上平台在內的多種分銷管道，提供西地那非（威而鋼）、他達拉非（希愛力）和伐地那非（艾力達）等藥物。例如，2023年7月，Haleon公司透過與Futura公司達成商業化協議，進入美國非處方勃起功能障礙藥物市場。 Futura公司研發的這款不含藥物成分的MED3000凝膠近期獲得了美國食品藥物管理局（FDA）的批准，成為一種新型醫療器材。 Futura公司的這款外用製劑最初投入了400萬美元用於商業化。

勃起功能障礙市場－競爭格局：

輝瑞公司、禮來公司、拜耳公司、Viatris公司、梯瓦製藥工業有限公司和波士頓科學公司是治療勃起功能障礙（ED）的主要市場參與者。這些公司正積極拓展產品線，在口服藥物、陰莖植入物以及幹細胞和衝擊波療法等新興再生療法方面不斷創新。隨著威而鋼和希愛力等重磅藥物的專利到期，學名藥和生物相似藥得以進入市場，市場競爭日益激烈。此外，策略合作、併購以及遠距醫療平台等數位醫療整合也在影響競爭格局。為了滿足不斷成長的全球患者群體的需求，創新、可及性和個人化治療方案成為市場關注的重點。例如，2024年2月，Petros Pharmaceuticals和23andMe與一家大型人工智慧軟體供應商合作，將先進技術融入其STENDRA（阿伐那非）非處方藥批准的自我選擇研究中。該人工智慧驅動的工具旨在提高篩檢準確性，確保按照 FDA 和 ACNU 指南安全獲取藥物，並加快 Petros 獲得非處方藥資格的進程。

目錄

第1章：勃起功能障礙市場概覽

  • 研究範圍
  • 市場估算年份

第2章：執行概要

  • 市集
    • 按應用分類的勃起功能障礙市場概覽
    • 按治療類型分類的勃起功能障礙市場概覽
    • 按產品類型分類的勃起功能障礙市場概覽
    • 按配銷通路分類的勃起功能障礙市場概覽
    • 各國勃起功能障礙市場概況
    • 按地區分類的勃起功能障礙市場概況
  • 競爭洞察

第3章：勃起功能障礙主要市場趨勢

  • 勃起功能障礙市場促進因素
    • 市場促進因素的影響分析
  • 勃起功能障礙市場限制
    • 市場限制因素的影響分析
  • 勃起功能障礙市場機遇
  • 勃起功能障礙市場未來趨勢

第4章：勃起功能障礙產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景分析
  • 規範架構分析

第5章：勃起功能障礙市場：地緣政治緊張局勢升級的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：勃起功能障礙市場概況

  • 2024年勃起功能障礙市佔率分析
  • 主要製造商細分數據
    • 知名球員分析
    • 新興參與者分析

第7章：勃起功能障礙市場－依應用領域分類

  • 概述
    • 按應用領域分類的細分市場佔有率分析
    • 腸外
    • 口服

第8章：勃起功能障礙市場－依治療類型分類

  • 概述
    • 按治療類型分類的細分市場佔有率分析
    • 藥物治療
    • 器械療法

第9章：勃起功能障礙市場－依產品類型分類

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 學名藥
      • 西地那非
      • 伐地那非
      • 前列地爾
      • 他達拉非
      • 其他
    • 品牌藥品
      • 希愛力
      • 齊德納
      • 威而鋼
      • 其他

第10章：勃起功能障礙市場－依配銷通路分類

  • 概述
    • 按治療類型分類的細分市場佔有率分析
    • 醫院藥房
    • 網路藥局
    • 零售藥局

第11章：勃起功能障礙市場－依地域分類

  • 介紹
    • 按地域分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美治療勃起功能障礙的主要生產商
    • 北美市場規模及預測（按國家/地區分類）
    • 北美市場規模及預測（按應用分類）
    • 北美市場規模及預測（按治療類型分類）
    • 北美市場規模及預測（依產品類型分類）
    • 北美市場規模及預測（按配銷通路分類）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲治療勃起功能障礙的主要生產者
    • 歐洲市場規模及預測（按國家/地區分類）
    • 歐洲市場規模及預測（按應用領域分類）
    • 歐洲市場規模及預測（依治療類型分類）
    • 歐洲市場規模及預測（依產品類型分類）
    • 歐洲市場規模及預測（依配銷通路分類）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區
    • 概述
    • 亞太地區治療勃起功能障礙的主要生產者
    • 亞太市場規模及預測（依國家/地區分類）
    • 亞太市場規模及預測（按應用分類）
    • 亞太地區市場規模及預測（依治療類型分類）
    • 亞太市場規模及預測（依產品類型分類）
    • 亞太市場規模及預測（按配銷通路分類）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲治療勃起功能障礙的主要生產商
    • 拉丁美洲市場規模及預測（按國家/地區分類）
    • 拉丁美洲市場規模及預測（按應用分類）
    • 拉丁美洲市場規模及預測（按治療類型分類）
    • 拉丁美洲市場規模及預測（依產品類型分類）
    • 拉丁美洲市場規模及預測（按配銷通路分類）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲治療勃起功能障礙的主要生產商
    • MEA市場規模及預測（依國家/地區分類）
    • MEA市場規模及預測（依應用分類）
    • MEA市場規模及預測（依治療類型分類）
    • MEA市場規模及預測（依產品類型分類）
    • MEA市場規模及預測（依配銷通路分類）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 中東和非洲其他地區

第12章：主要供應商分析－勃起功能障礙產業

  • 競爭基準化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司簡介
    • Bayer AG
    • Lilly
    • Petros Pharmaceuticals, Inc.
    • Pfizer Inc.
    • GlaxoSmithKline PLC
    • Teva Pharmaceutical
    • Sanofi
    • Industries Ltd
    • Lupin Limited
    • Futura Medical
    • Cure Pharmaceutical
    • Sun Pharmaceutical Industries Ltd
    • VIVUS, Inc.
    • Auxilium Pharmaceuticals, Inc.
    • Others

第13章：360度AnalystView

第14章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5766

Erectile Dysfunction Market size was valued at US$ 2,567.87 Million in 2024, expanding at a CAGR of 8.2% from 2025 to 2032.

Erectile dysfunction (ED) is defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity. It is a multifactorial condition resulting from vascular, neurological, hormonal, or psychological causes that has a significant impact on men's physical and emotional health. The rising global prevalence of chronic diseases such as cardiovascular disorders and diabetes, both of which contribute significantly to ED, as well as sedentary lifestyles and stress-related conditions, is a key market driver. In contrast, the market is restrained by the loss of patent protection for blockbuster drugs such as Viagra and Cialis, which has resulted in price erosion and intense competition from generics. Nonetheless, an emerging opportunity is the development of next-generation oral therapies, stem-cell-based treatments, and digital health platforms that provide confidential online consultations and prescriptions. These innovations, combined with a growing acceptance of sexual wellness as part of men's health, are expected to drive the erectile dysfunction market's long-term growth and modernization.

Erectile Dysfunction Market- Market Dynamics

Rising Prevalence of Lifestyle-Related Diseases To Propel Growth In The Market

The increasing prevalence of lifestyle-related diseases is expected to fuel the erectile dysfunction market. Lifestyle-related diseases are health conditions that are primarily caused by unhealthy habits such as poor diet, lack of exercise, smoking, and binge drinking. The rise in lifestyle-related diseases is attributed to increased sedentary behavior, poor dietary habits, stress, and unhealthy habits such as smoking and excessive alcohol consumption. Erectile dysfunction (ED) is an early warning sign for lifestyle-related diseases such as cardiovascular disease and diabetes, emphasizing the importance of prompt medical attention and healthier lifestyle choices. For instance, according to a report published in May 2022 by the World Obesity Federation, a non-profit organization based in the United Kingdom, by 2030, one billion people worldwide, including one in every five women and one in every seven men, are expected to be obese, rising to 4 billion people, or 51% of the global population, by 2035. As a result, the increasing prevalence of lifestyle-related diseases will drive growth in the erectile dysfunction industry.

Erectile Dysfunction Market- Segmentation Analysis:

The Global Erectile Dysfunction Market is segmented by Application, Therapy Type, Product Type, Distribution Channel and Region.

According to the Application, Oral medication is the highest revenue-generating segment in the global erectile dysfunction drugs market in 2025, owing to an increase in the use of oral medications such as Cialis, Stendra, Viagra, and others, which can be self-administered and are cost-effective, as well as increasing partnerships and collaborations among market players. For instance, in May 2022, Laboratorios Rubio S.A. sold the prescription medication BANDOL (sildenafil oral suspension) to Aspargo Laboratories, Inc. BANDOL is used to treat erectile dysfunction. Concurrently with this acquisition, Aspargo signed a distribution agreement with Rubio to continue marketing and promoting BANDOL in the Spanish market.

By Distribution Channel, Online pharmacies are the most important selling channel in the global erectile dysfunction drugs market, owing to the rising incidence of erectile dysfunction, which is driving the adoption of alternative treatments for faster and more effective results, as well as the increased launch of advanced platforms. For example, in October 2023, Mangoceuticals, Inc., a company dedicated to the development, marketing, and sale of a range of men's health and wellness products through a secure telemedicine platform, including its specially formulated erectile dysfunction (ED) medication under the brand name "Mango," will launch its affiliate marketing program via its newly revamped website.

Erectile Dysfunction Market- Geographical Insights

North America is a significant revenue-generating region in the erectile dysfunction (ED) drugs market, thanks to a high prevalence of ED, advanced healthcare infrastructure, and widespread patient education. The region benefits from strong R&D capabilities as well as the presence of leading pharmaceutical companies like Pfizer Inc. (Viagra) and Eli Lilly and Company (Cialis), which are constantly innovating through novel formulations and combination therapies. High disposable incomes, improved access to healthcare, and favorable reimbursement frameworks all contribute to long-term market demand. However, patent expirations and the increasing availability of generic alternatives have increased competition and influenced pricing strategies. According to Oxford Academic (February 2024), the average ED prevalence rate in North America was 20.7%, with a steady increase observed across age groups and among individuals with associated health comorbidities, highlighting the region's continued clinical and commercial importance.

United States Erectile Dysfunction Market- Country Insights

The United States makes a significant contribution to the North American erectile dysfunction drug market. A large aging population, lifestyle-related diseases such as diabetes and hypertension, and rising awareness of erectile dysfunction treatment options all contribute to market growth. Pharmaceutical companies such as Pfizer and Eli Lilly have a significant presence, providing medications such as sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra) through a variety of distribution channels, including retail pharmacies and online platforms. For example, in July 2023, Haleon entered the US OTC erectile dysfunction market with a commercialization agreement for Futura's drug-free MED3000 gel, which was recently approved by the FDA as a de novo medical device. Futura's topical treatment, which was recently approved by the US Food and Drug Administration as an over-the-counter medical device, cost $4 million to commercialize initially.

Erectile Dysfunction Market- Competitive Landscape:

Pfizer Inc., Eli Lilly and Company, Bayer AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., and Boston Scientific Corporation are among the top Erectile Dysfunction (ED) market players. These companies are actively diversifying their product offerings with innovations in oral medications, penile implants, and emerging regenerative therapies like stem cell and shockwave treatments. The market is experiencing increased competition as patents for blockbuster drugs such as Viagra and Cialis expire, allowing generics and biosimilars to enter the marketplace. In addition, strategic collaborations, mergers, and digital health integrations such as telemedicine platforms for prescription and consultation are influencing competitive dynamics. To meet the needs of a growing global patient base, the landscape prioritizes innovation, accessibility, and personalized treatment options. For instance, in February 2024, Petros Pharmaceuticals and 23andMe collaborated with a major AI software provider to incorporate advanced technology into its Self-Selection Study for STENDRA (avanafil) OTC approval. The AI-driven tool aimed to improve screening accuracy, ensure safe medication access in accordance with FDA and ACNU guidelines, and accelerate Petros' path to OTC status.

Recent Developments:

In March 2024, Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved OPSYNVI, a single-tablet combination of macitentan, an endothelin receptor antagonist (ERA), and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor, for the chronic treatment of adults with pulmonary arterial hypertension (PAH, World Health Organization [WHO] Group I) and WHO functional class II-III.1 OPSYNVI(R) can be used for PAH patients who are treatment-naive or already taking an ERA, PDE5 inhibitor, or both.

In July 2024, Aspargo Labs, Inc., a speciality pharmaceutical and MedTech company focused on transforming drug delivery through innovative oral sprays, today announced the release of a Phase 1 study demonstrating that ASP-001, an investigative sildenafil oral spray in development for erectile dysfunction (ED), achieves absorption within five minutes, which is twice as fast as traditional sildenafil tablets.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL ERECTILE DYSFUNCTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Bayer AG
  • Lilly
  • Petros Pharmaceuticals, Inc.
  • Pfizer Inc.
  • GlaxoSmithKline PLC
  • Teva Pharmaceutical
  • Sanofi
  • Industries Ltd
  • Lupin Limited
  • Futura Medical
  • Cure Pharmaceutical
  • Sun Pharmaceutical Industries Ltd
  • VIVUS, Inc.
  • Auxilium Pharmaceuticals, Inc.
  • Others

GLOBAL ERECTILE DYSFUNCTION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Parenteral
  • Oral

GLOBAL ERECTILE DYSFUNCTION MARKET, BY THERAPY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Drug Therapy
  • Device Therapy

GLOBAL ERECTILE DYSFUNCTION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Generic Drugs
  • Sildenafil
  • Vardenafil
  • Alprostadil
  • Tadalafil
  • Others
  • Branded Drugs
  • Cialis
  • Zydena
  • Viagra
  • Others

GLOBAL ERECTILE DYSFUNCTION MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

GLOBAL ERECTILE DYSFUNCTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Erectile Dysfunction Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Erectile Dysfunction Market Snippet by Application
    • 2.1.2. Erectile Dysfunction Market Snippet by Therapy Type
    • 2.1.3. Erectile Dysfunction Market Snippet by Product Type
    • 2.1.4. Erectile Dysfunction Market Snippet by Distribution Channel
    • 2.1.5. Erectile Dysfunction Market Snippet by Country
    • 2.1.6. Erectile Dysfunction Market Snippet by Region
  • 2.2. Competitive Insights

3. Erectile Dysfunction Key Market Trends

  • 3.1. Erectile Dysfunction Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Erectile Dysfunction Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Erectile Dysfunction Market Opportunities
  • 3.4. Erectile Dysfunction Market Future Trends

4. Erectile Dysfunction Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Erectile Dysfunction Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Erectile Dysfunction Market Landscape

  • 6.1. Erectile Dysfunction Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Erectile Dysfunction Market - By Application

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 7.1.2. Parenteral
    • 7.1.3. Oral

8. Erectile Dysfunction Market - By Therapy Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapy Type, 2024 & 2032 (%)
    • 8.1.2. Drug Therapy
    • 8.1.3. Device Therapy

9. Erectile Dysfunction Market - By Product Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 9.1.2. Generic Drugs
      • 9.1.2.1. Sildenafil
      • 9.1.2.2. Vardenafil
      • 9.1.2.3. Alprostadil
      • 9.1.2.4. Tadalafil
      • 9.1.2.5. Others
    • 9.1.3. Branded Drugs
      • 9.1.3.1. Cialis
      • 9.1.3.2. Zydena
      • 9.1.3.3. Viagra
      • 9.1.3.4. Others

10. Erectile Dysfunction Market - By Distribution Channel

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Therapy Type, 2024 & 2032 (%)
    • 10.1.2. Hospital Pharmacies
    • 10.1.3. Online Pharmacies
    • 10.1.4. Retail Pharmacies

11. Erectile Dysfunction Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Erectile Dysfunction Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Erectile Dysfunction Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Erectile Dysfunction Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Erectile Dysfunction Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Erectile Dysfunction Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Erectile Dysfunction Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Bayer AG
    • 12.2.2. Lilly
    • 12.2.3. Petros Pharmaceuticals, Inc.
    • 12.2.4. Pfizer Inc.
    • 12.2.5. GlaxoSmithKline PLC
    • 12.2.6. Teva Pharmaceutical
    • 12.2.7. Sanofi
    • 12.2.8. Industries Ltd
    • 12.2.9. Lupin Limited
    • 12.2.10. Futura Medical
    • 12.2.11. Cure Pharmaceutical
    • 12.2.12. Sun Pharmaceutical Industries Ltd
    • 12.2.13. VIVUS, Inc.
    • 12.2.14. Auxilium Pharmaceuticals, Inc.
    • 12.2.15. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us